Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Wins $338K from US Air Force to Develop Arrays to Detect Pathogens

NEW YORK, Sept. 28 (GenomeWeb News) - CombiMatrix has won a one-year, $338,000 contract from the US Air Force to develop and produce microarrays that detect pathogens, its parent company, Acacia Research, said today.

 

Under the agreement, CombiMatrix will develop microarrays to detect pathogens that cause upper respiratory infections and that infect wounds. The first array will identify upper respiratory infections that can cause pneumonia, bird flu, and SARS. The Air Force Institute of Occupational Health has committed to purchasing the arrays for evaluation and use. CombiMatrix will be able to make them commercially available to other users as well.

 

The contract results from a prior collaboration with the AFIOH that led to the development of a microarray to identify different serotypes of influenza A.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.